These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Incidence of adverse effects following metrizamide myelography in nonambulatory and ambulatory patients. Sykes RH, Wasenaar W, Clark P. Radiology; 1981 Mar; 138(3):625-7. PubMed ID: 7465839 [Abstract] [Full Text] [Related]
6. Metrizamide compared with iohexol for cervical myelography: a double-blind study. Reisin R, Ethier R, de la Sayette V, Melanson D, Eng F. Can Assoc Radiol J; 1988 Jun; 39(2):107-10. PubMed ID: 2967830 [Abstract] [Full Text] [Related]
8. [Experimental and clinical studies on the diagnostic value of CT-myelography using a water-soluble contrast medium, metrizamide]. Nagase J. Nihon Seikeigeka Gakkai Zasshi; 1982 Nov; 56(11):1569-86. PubMed ID: 6761403 [Abstract] [Full Text] [Related]
9. Complications of myelography after partial metrizamide withdrawal. Hodges SD, Berasi CC. Spine (Phila Pa 1976); 1987 Nov; 12(1):53-5. PubMed ID: 3576356 [Abstract] [Full Text] [Related]